Advertisement

Effectiveness of therapeutic lifestyle changes in patients with hypertension, hyperlipidemia, and/or hyperglycemia

      In this prospective study of 2,390 ethnically diverse men and women, we evaluated the clinical effectiveness of 12 weeks of participation in a community-based lifestyle management program in helping patients who had hypertension, hyperlipidemia, and/or impaired fasting glucose or diabetes mellitus achieve goal risk factor levels without using pharmacotherapeutic agents. Although further research is warranted, the findings clearly show that many patients who have conventional risk factors for coronary heart disease can achieve goal levels without medications within 12 weeks of initiating therapeutic lifestyle changes and refute the notion that intensive lifestyle intervention is not worth the effort.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Khot U.N.
        • Khot M.B.
        • Bajzer T.
        • Sapp S.K.
        • Ohman M.
        • Brener S.J.
        • Ellis S.G.
        • Lincoff A.M.
        • Topol E.J.
        Prevalence of conventional risk factors in patients with coronary heart disease.
        JAMA. 2003; 290: 898-904
        • Greenland P.
        • Knoll M.D.
        • Stamler J.
        • Neaton J.D.
        • Dyer A.R.
        • Garside D.B.
        • Wilson P.W.
        Major risk factors as antecedents of fatal and nonfatal coronary heart disease events.
        JAMA. 2003; 290: 891-897
        • Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults
        Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
        JAMA. 2001; 285: 2486-2497
        • Mosca L.
        • Appel L.G.
        • Benjamin E.J.
        • Berra K.
        • Chandra-Strobos N.
        • Fabunmi R.P.
        • Grady D.
        • Haan C.K.
        • Hayes S.N.
        • Judelson D.R.
        • et al.
        AHA guidelines.
        Circulation. 2004; 109: 672-693
        • Gordon N.F.
        • Salmon R.D.
        • Mitchell B.S.
        • Faircloth G.C.
        • Levinrad L.I.
        • Salmon S.
        • Saxon W.E.
        • Reid K.S.
        Innovative approaches to comprehensive cardiovascular disease risk reduction in clinical and community-based settings.
        Curr Atheroscler Rep. 2001; 3: 498-506
        • Gordon N.F.
        • English C.D.
        • Contractor A.S.
        • Salmon R.D.
        • Leighton R.F.
        • Franklin B.A.
        • Haskell W.L.
        Effectiveness of three models for comprehensive cardiovascular disease risk reduction.
        Am J Cardiol. 2002; 89: 1263-1268
        • Smith S.C.
        • Blair S.N.
        • Bonow R.O.
        • Brass L.M.
        • Cerqueira M.D.
        • Dracup K.
        • Fuster V.
        • Gotto A.
        • Grundy S.M.
        • Miller N.H.
        • et al.
        AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update.
        Circulation. 2001; 104: 1577-1579
        • Pearson T.A.
        • Blair S.N.
        • Daniels S.R.
        • Eckel R.H.
        • Fair J.M.
        • Fortmann S.P.
        • Franklin B.A.
        • Goldstein L.B.
        • Greenland P.
        • Grundy S.M.
        • et al.
        AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update.
        Circulation. 2002; 106: 388-391
        • Chobanian A.V.
        • Bakris G.L.
        • Black H.R.
        • Cushman W.C.
        • Green L.A.
        • Izzo J.L.
        • Jones D.W.
        • Materson B.J.
        • Oparil S.
        • Wright J.T.
        • Roccella E.J.
        • National High Blood Pressure Education Program Coordinating Committee
        The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
        JAMA. 2003; 289: 2560-2572
      1. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. NIH Publication 98-4083. National Heart, Lung, and Blood Institute 1998.

        • American Diabetes Association
        Standards of medical care for patients with diabetes mellitus.
        Diabetes Care. 2003; 26: S33-S50
      2. Franklin B.A. Whaley M.H. Howley E.T. American College of Sports Medicine. ACSM'S Guidelines for Exercise Testing and Prescription. 6th Ed. Lippincott Williams and Wilkins, Philadelphia2000
        • Kraus R.M.
        • Eckel R.H.
        • Howard B.
        • Appel L.J.
        • Daniels S.R.
        • Deckelbaum R.J.
        • Erdman J.W.
        • Kris-Etherton P.
        • Goldberg I.J.
        • Kotchen T.A.
        • et al.
        AHA dietary guidelines.
        Circulation. 2000; 102: 2284-2299
        • Thompson P.D.
        • Buchner D.
        • Pina I.L.
        • Balady G.J.
        • Williams M.A.
        • Marcus B.H.
        • Berra K.
        • Blair S.N.
        • Costa F.
        • Franklin B.
        • et al.
        AHA scientific statement: exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease.
        Circulation. 2003; 107: 3109-3116
        • Ornish D.
        • Brown S.E.
        • Scherwitz L.W.
        • Billings J.H.
        • Armstrong W.T.
        • Ports L.W.
        • McLanahan S.M.
        • Kirkeeide R.L.
        • Brand R.J.
        • Gould K.L.
        Can lifestyle changes reverse heart disease? The Lifestyle Heart Trial.
        Lancet. 1990; 336: 129-133
        • Tuomilehto J.
        • Lindström J.
        • Eriksson J.G.
        • Valle T.T.
        • Hämäläinen H.
        • Ilanne-Parikka P.
        • Keinäen-Kiukaanniemi S.
        • Laaksso M.
        • Louheranta A.
        • Rastas M.
        • et al.
        • Finnish Diabetes Prevention Study Group
        Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
        N Engl J Med. 2001; 344: 1343-1350
        • Diabetes Prevention Program Research Group
        Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
        N Engl J Med. 2002; 346: 393-403
        • PREMIER Collaborative Research Group
        Effects of comprehensive lifestyle modification on blood pressure control.
        JAMA. 2003; 289: 2083-2093